J. L. Galman, H. C. Hailes / Tetrahedron: Asymmetry 20 (2009) 1828–1831
1831
4.5. (2S,30S)-3,3,3-Trifluoro-2-methoxy-2-phenyl propionic acid
nals of 4c and 5c). Rf = 0.45 (EtOAc/hexane, 1:1); ½a D20
ꢁ
¼ ꢀ10:6 (c
30,40-dihydroxy-20-oxo-butyl ester 5b
0.25, CHCl3); 1H NMR (500 MHz; CDCl3) d 3.38 (3H, s, OCH3), 3.61
(3H, s, OCH3) 3.57–3.70 (2H, m, CH2), 4.36 (1H, m, CHOH), 5.02
(0.74H, d, J 17.5, CHHO (2S,30S)), 5.13 (0.81H, d, J 17.5, CHHO
(2S,30R)), 5.17 (0.38H, d, J 17.5, CHHO (2S,30R)), 5.29 (0.81H, d, J
17.5, CHHO (2S,30S)), 7.42 (3H, m, Ph), 7.62 (2H, m, Ph); 13C NMR
(150 MHz; CDCl3) d 55.8 (OCH3), 59.5 (OCH3), 68.1, 72.8, 75.0,
84.5 (q, JCF 27, CCF3), 123.1 (q, JCF 285, CF3), 127.5, 128.5, 129.8,
131.5, 166.1 (C@O ester), 202.9 (C@O, ketone); 19F NMR
(282 MHz; CDCl3) d ꢀ72.2.
The same procedure was used as that described above for 4b
using (R)-MTPA chloride to give 5b as a colourless oil (0.044 g,
51%) (2S,30S) >95% ee (from integrations of Ha and Hb 1H NMR sig-
nals of 4b and 5b). Rf = 0.45 (EtOAc); ½a D20
ꢁ
¼ ꢀ14:4 (c 0.5, CHCl3), 1H
NMR (500 MHz; CDCl3) d 3.63 (3H, s, OMe), 3.92 (2H, m, CH2OH),
4.35 (1H, dd, J 4.0 and 3.8, CHOH), 5.05 (1H, d, J 17.0, CHHO
(2S,30S)), 5.23 (1H, d, J 17.0, CHHO (2S,30S)), 7.43 (3H, m, Ph), 7.62
(2H, m, Ph), no (2S,30R isomer detected); 13C NMR (125 MHz;
CDCl3) d 55.8 (OCH3), 63.5, 67.9, 76.3, 84.6 (q, JCF 28, CCF3), 123.1
(q, JCF 288, CF3), 127.5, 128.5, 129.9, 131.7, 166.4 (C@O ester),
203.1 (C@O, ketone); 19F NMR (282 MHz; CDCl3) d ꢀ72.2.
4.9. (2R,30RS)-3,3,3-Trifluoro-2-methoxy-2-phenyl propionic
acid 30-hydroxy-20-oxo-30-phenylpropyl ester 4d
The same procedure was used as that described above for 4c
using (S)-MTPA chloride and 2d.13 The product was purified using
flash silica chromatography (EtOAc/hexane, 1:4) to give 4d as a col-
ourless oil (0.014 g, 61%). 1H NMR (500 MHz; CDCl3) d 3.62 (3H, s,
OCH3), 4.71 (0.25H, d, J 16.9, CHHO (2R,30R)), 4.86 (0.25H, d, J 16.9,
CHHO (2R,30S)), 4.91 (0.25H, d, J 16.9, CHHO (2R,30S)), 5.02 (0.25H,
d, J 16.9, CHHO (2R,30R)), 5.25 (1H, m, CHOH), 7.34–7.54 (6H, m,
Ph), 7.70 (2H, m, Ph), 8.01 (2H, J 8.6, Ph).
4.6. 1, 3-Dihydroxy-4-methoxy-butan-2-one 2c
ThDP (22 mg, 48
lmol) and MgCl2ꢂ6H2O (39 mg, 180
lmol)
were dissolved in H2O (10 mL) and the pH was adjusted to 7 with
0.1 M NaOH. To this stirred solution, at 25 °C, was added WT-TK
clarified lysate (2 mL)11c,12 and the mixture was stirred for
20 min. In another flask, 1 (110 mg, 1 mmol) and 3c (74 mg,
1 mmol) were dissolved in H2O (8 mL) and the pH was adjusted
to 7 with 0.1 M NaOH. Following the 20-min enzyme/cofactor
pre-incubation, the 1/3c mixture was added to the enzyme solu-
tion and the mixture was stirred at 25 °C for 24 h. During this time,
the pH was maintained at 7.0 by addition of 1 M HCl using a pH
stat (Stat Titrino, Metrohm). Silica was added and the reaction mix-
ture was concentrated to dryness before dry loading onto a flash
silica gel column. Following column purification (EtOAc/CH3OH,
Acknowledgements
We thank the EPSRC for a DTA studentship to J.L.G, and Abil
Aliev for helpful discussions. We thank the EPSRC National Mass
Spectrometry Service Centre, Swansea University, for the provision
of high resolution MS data.
80:20), 2c was isolated as an oil (40 mg, 30%). ½a D20
¼ þ2:0 (c 2.0,
ꢁ
CHCl3), lit.18
½
a 2J 5
ꢁ
¼ þ3:0 (c 0.017, MeOH); mmax (KBr)/cmꢀ1
References
3415br s, 2923s, 1727s; 1H NMR (300 MHz; CDCl3) d 3.36 (3H, s,
OCH3), 3.61 (1H, dd, J 9.9 and 4.4, CHHOMe), 3.70 (1H, dd, J 9.9
and 4.4, CHHOMe), 4.38 (1H, dd, J 4.4 and 4.4, CHOH), 4.43 (1H,
1. For example: (a) Lindner, W. Chromatographia 1987, 24, 97–107; (b) Hailes, H.
C.; Madden, J. Synlett 1999, 105–107.
2. Wenzel, T. J.; Morin, C. A.; Brechting, A. A. J. Org. Chem. 1992, 57, 3594–3599.
3. Dale, J. A.; Mosher, H. S. J. Am. Chem. Soc. 1973, 95, 512–519.
4. Pehk, T.; Lippmaa, E.; Lopp, M.; Paju, A.; Borer, B. C.; Taylor, R. J. K. Tetrahedron:
Asymmetry 1993, 4, 1527–1532.
d,
J 19.7, CHHOH), 4.53 (1H, d, J
19.7, CHHOH); 13C NMR
(75 MHz; CDCl3) d 59.5 (OCH3), 66.7 (CH2), 73.4 (CH2), 74.8 (CHOH)
210.8 (C@O); m/z (FTMS) [M+NH4] calcd for C5H14O4N, 152.0917;
found 152.0919.
5. Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Am. Chem. Soc. 1991, 113,
4092–4096.
6. Allen, D. A.; Tomaso, A. E.; Priest, O. P.; Hindson, D. F.; Hurlburt, J. L. J. Chem.
Educ. 2008, 85, 698–700.
7. Satoh, T.; Onda, K.; Yamakawa, K. J. Org. Chem. 1991, 56, 4129–4134.
8. Kobori, Y.; Myles, D. C.; Whitesides, G. M. J. Org. Chem. 1992, 57, 5899–5907.
9. Ingram, C. U.; Bommer, M.; Smith, M. E. B.; Dalby, P. A.; Ward, J. M.; Hailes, H.
C.; Lye, G. J. Biotechnol. Bioeng. 2007, 96, 559–569.
10. (a) Kaulmann, U.; Smithies, K.; Smith, M. E. B.; Hailes, H. C.; Ward, J. M. Enzyme
Microb. Technol. 2007, 41, 628–637; (b) Smithies, K.; Smith, M. E. B.; Kaulmann,
U.; Galman, J. L.; Ward, J. M.; Hailes, H. C. Tetrahedron: Asymmetry 2009, 20,
570–574.
11. For example: (a) Hobbs, G. R.; Lilly, M. D.; Turner, N. J.; Ward, J. M.; Willets, A.
J.; Woodley, J. M. J. Chem. Soc., Perkin Trans. 1 1993, 165–166; (b) Hecquet, L.;
Bolte, J.; Demuynck, C. Tetrahedron 1994, 50, 8677–8684; (c) Hibbert, E. G.;
Senussi, T.; Costelloe, S. J.; Lei, W.; Smith, M. E. B.; Ward, J. M.; Hailes, H. C.;
Dalby, P. A. J. Biotechnol. 2007, 131, 425–432; (d) Hibbert, E. G.; Senussi, T.;
Smith, M. E. B.; Costelloe, S. J.; Ward, J. M.; Hailes, H. C.; Dalby, P. A. J. Biotechnol.
2008, 134, 240–245.
12. Smith, M. E. B.; Hibbert, E. G.; Jones, A. B.; Dalby, P. A.; Hailes, H. C. Adv. Synth.
Catal. 2008, 350, 2631–2638.
13. Smith, M. E. B.; Smithies, K.; Senussi, T.; Dalby, P. A.; Hailes, H. C. Eur. J. Org.
Chem. 2006, 1121–1123.
14. Enders, D.; Voith, M.; Ince, S. J. Synthesis 2002, 1775–1779.
15. Smith, M. E. B.; Kaulmann, U.; Ward, J. M.; Hailes, H. C. Bioorg. Med. Chem. 2006,
14, 7062–7065.
16. Konno, K.; Fujishima, T.; Liu, Z.; Takayama, H. Chirality 2002, 13, 72–80.
17. (a) Yasuhara, F.; Yamaguchi, S.; Kasai, R.; Tanaka, O. Tetrahedron Lett. 1986, 27,
4033–4034; (b) Tsuda, M.; Toriyabe, Y.; Endo, T.; Kobayashi, J. Chem. Pharm.
Bull. 2003, 51, 448–451; (c) Akiyama, K.; Kawamoto, S.; Fujimoto, H.; Ishibashi,
M. Tetrahedron Lett. 2003, 44, 8427–8431; (d) Czuba, I. R.; Zammit, S.;
Rizzacasa, M. A. Org. Biomol. Chem. 2003, 1, 2044–2056.
4.7. (2R,30S)-3,3,3-Trifluoro-2-methoxy-2-phenyl propionic acid
30-hydroxy-40-methoxy-20-oxo-butyl ester 4c
The reaction was carried out under anhydrous conditions. To a
stirred solution of 2c (0.010 g, 0.07 mmol) in CH2Cl2 (3 mL) were
added triethylamine (34
lL, 0.25 mmol) and (S)-MTPA chloride
(20 L, 0.11 mmol) in CH2Cl2 (2 mL) and the reaction mixture
l
was stirred for 12 h at rt. The product was dry loaded onto silica
gel and purified using flash chromatography (EtOAc/hexane, 1:1)
to afford 4c as a colourless oil (0.015 g, 61%), (2R,30S) 57% ee (from
integrations of Ha and Hb 1H NMR signals of 4c and 5c). Rf = 0.40
(EtOAc/hexane,1:1); ½a D20
¼ þ23:2 (c 0.25, CHCl3); mmax (KBr)/
ꢁ
cmꢀ1 3415br s, 2923s, 1727s; 1H NMR (300 MHz; CDCl3) d 3.38
(3H, s, OCH3), 3.61 (3H, s, OCH3) 3.57–3.70 (2H, m, CH2), 4.36
(1H, m, CHOH), 5.02 (0.16H, d, J 17.5, CHHO (2R,30R)), 5.13
(0.84H, d, J 17.5, CHHO (2R,30S)), 5.17 (0.81H, d, J 17.5, CHHO
(2R,30S)), 5.29 (0.16H, d, J 17.5, CHHO (2R,30R)), 7.42 (3H, m, Ph),
7.62 (2H, m, Ph); m/z (FTMS) [M+NH4] calcd for C15H21F3O6N,
368.1315; found 368.1318.
4.8. (2S,30S)-3,3,3-Trifluoro-2-methoxy-2-phenyl propionic acid
30-hydroxy-40-methoxy-20-oxo-butyl ester 5c
18. Dalmas, V.; Demuynck, C. Tetrahedron: Asymmetry 1993, 4, 2383–2388.
19. Fetizon, M.; Goulaouic, P.; Hanna, I. Tetrahedron Lett. 1985, 26, 4925–4927.
20. Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J.
Organometallics 1996, 15, 1518–1520.
The same procedure was used as that described above for 4c
using (R)-MTPA chloride to give 5c as a colourless oil (0.010 g,
40%) (2S,30S) 57% ee (from integrations of Ha and Hb 1H NMR sig-
21. Dickens, F. Biochem. Prep. 1962, 9, 86–91.